India, 10th Aug, 2026 – Leucine Rich Bio Pvt Ltd, South Asia’s first microbiome company and the force behind the BugSpeaks brand, will host the 3rd edition of World of Microbiome 2026 on 21 August 2026 at Hotel GreenPark, Bengaluru. The one-day flagship conference will bring together clinicians, researchers, nutritionists, biotech leaders, entrepreneurs, investors and wellness professionals to advance microbiome science and its applications in preventive healthcare and precision wellness.
Building on the success of previous editions, the 2026 event will feature focused sessions on microbiota in health and wellness, intellectual property and clinical trials in the wellness domain, and precision nutrition and the microbiome. Panel discussions will examine enablers of next-generation diagnostics and therapeutics as well as microbiome trends outside India. The schedule of the event is from 10:00 am – 5:30 pm and will consist of inauguration, presentations by experts, networking sessions, and a quiz for the participants.
The list of confirmed speakers include : Dr. Debojyoti Dhar, Co-founder & Director, Leucine Rich Bio; Mr. Kumar Sankaran, Founder & CEO, BugSpeaks; Dr. Astha Agrawal; Dr. Yugandhar Reddy from Unilever India; Dr. Kiran Ambatipudi from IIT Roorkee; Dr. Lipika Sahoo; Dr. Mukul Maurya; Dt. Rohini Prasad of BugSpeaks; and other leading voices from clinical practice, industry and academia.
“World of Microbiome is not merely a conference but a platform which facilitates translation of microbiome research into clinical and wellness benefits in South Asia and beyond,” stated Dr. Debojyoti Dhar, Co-Founder & Director, Leucine Rich Bio. “As we meet in the third edition of the conference, we look forward to furthering collaborations to expedite precision nutrition, diagnostics, and healthcare through the microbiomes of our communities.” Stated Mr Kumar Sankaran, Founder and CEO, Leucine Rich Bio Pvt Ltd. Mr Prabhath Manjappa, Co-founder and CPO opined “This is a platform that enables discussion around new age science of microbiome, AI in healthcare, precision healthcare etc”.
Conducted by Leucine Rich Bio, founders of the first clinically validated gut microbiome test in South Asia named BugSpeaks, the conference aims at continuing the vision of the company to facilitate knowledge sharing, collaboration and practical applications of microbiome research. Leucine Rich Bio has a decade-long legacy of working alongside over 100 clinical and 50 industrial partners in 15+ countries around the world.
About Leucine Rich Bio-
Leucine Rich Bio Pvt Ltd is South Asia’s pioneering microbiome company, headquartered in Bengaluru. Its flagship brand, BugSpeaks, offers advanced microbiome testing (gut, skin and expanding panels) powered by next-generation sequencing, proprietary algorithms and curated databases. The company holds ISO 9001, ISO/IEC 17025, NABL and NABH accreditations and has supported clinical research demonstrating the impact of microbiota-based personalised nutrition. Through initiatives such as World of Microbiome, Leucine Rich Bio advances scientific dialogue and practical applications in precision health and wellness.
